Ret Proto-Oncogene Antikörper (pTyr1015)
Kurzübersicht für Ret Proto-Oncogene Antikörper (pTyr1015) (ABIN7182607)
Target
Alle Ret Proto-Oncogene (RET) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- pTyr1015
-
Kreuzreaktivität
- Human, Affe, Maus, Ratte
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from Human Ret around the phosphorylation site of Y1015.
-
Isotyp
- IgG
-
-
anti-Ret Proto-Oncogene (RET) (AA 702-848) antibody
RET Reaktivität: Human IHC, StM Wirt: Maus Monoclonal RET-2795 unconjugated
anti-Ret Proto-Oncogene (RET) (AA 1-1072) antibodyRET Reaktivität: Human WB, PLA Wirt: Kaninchen Polyclonal unconjugated
anti-Ret Proto-Oncogene (RET) (AA 702-848) antibodyRET Reaktivität: Human ELISA, Coat Wirt: Maus Monoclonal RET-2663 unconjugated
anti-Ret Proto-Oncogene (RET) (AA 1012-1042), (C-Term) antibodyRET Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB01561 unconjugated
anti-Ret Proto-Oncogene (RET) (AA 152-182), (N-Term) antibodyRET Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB00705 unconjugated
anti-Ret Proto-Oncogene (RET) (AA 29-300) antibodyRET Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Ret Proto-Oncogene (RET) (AA 361-458) antibodyRET Reaktivität: Human WB, ELISA, PLA Wirt: Maus Monoclonal 1A5 unconjugated
anti-Ret Proto-Oncogene (RET) (C-Term) antibodyRET Reaktivität: Human, Maus, Ratte WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Ret Proto-Oncogene (RET) (pTyr1062) antibodyRET Reaktivität: Human, Maus, Ratte WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Ret Proto-Oncogene (RET) (AA 541-553), (Extracellular) antibodyRET Reaktivität: Human WB, IHC, IF, FACS, IC, LCI Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- WB:1:500-1:2000, ELISA:1:5000,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Ret Proto-Oncogene (RET)
-
Andere Bezeichnung
- RET
-
Hintergrund
- C ret antibody, Cadherin family member 12 antibody, Cadherin related family member 16 antibody, CDHF 12 antibody, CDHF12 antibody, CDHR16 antibody, ELKS Fusion gene antibody, HSCR 1 antibody, HSCR1 antibody, Hydroxyaryl protein kinase antibody, MEN2A antibody, MEN2B antibody, MTC 1 antibody, MTC1 antibody, Multiple endocrine neoplasia and medullary thyroid carcinoma 1 antibody, Oncogene RET antibody, Proto oncogene tyrosine protein kinase receptor ret antibody, Proto-oncogene c-Ret antibody, Proto-oncogene tyrosine-protein kinase receptor ret antibody, PTC antibody, RET antibody, RET ELE1 antibody, Ret Proto oncogene antibody, RET transforming sequence antibody, RET_HUMAN antibody, RET51 antibody, RET9 antibody, tyrosine-protein kinase receptor ret antibody
-
UniProt
- P07949
-
Pathways
- RTK Signalweg, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
Target
-
